Company Description
Theranica’s drug-free migraine treatment device is based on recent advances in neuroscience. The company’s device, Nerivio®, is a digitally connected wearable arm band that utilizes Theranica’s patented remote electrical neuromodulation technology. Nerivio stimulates the body’s pain receptors in order to relieve acute and chronic migraine pain ‒ easily and safely. Nerivio is FDA approved for acute treatment of migraine and is under FDA review for preventive treatment. To date, Nerivio has been prescribed to over 35,000 patients in the US.
The company was founded by Shimon Eckhouse, a leading Israeli MedTech entrepreneur who has founded more than 20 startups; CEO Alon Ironi, an experienced entrepreneur; COO Ronen Jashek, an international marketing, sales, and business development executive; and VP R&D Slava Barabash, a seasoned wireless communications technologist. The company’s medical and scientific team includes a solid group of PhDs in neuroscience, backed by a medical advisory board which includes the world’s top headache specialists.
The details here are based on information received from, and verified solely by, the company.
